Hepatic Impairment Terminated Phase 1 Trials for Tozadenant (DB12203)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03212313Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of TozadenantBasic Science